Condition
Kidney Failure
ClinicalTrials.gov condition label
How to interpret these research links
Connected source recordsThis is the original ClinicalTrials.gov condition label, found in 35 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
35 shownMultifactorial Intervention to Reduce Cardiovascular Disease in Type 1 DiabetesNCT06082063 · 2024-07-01
RECRUITINGTenofovir Exposures in Advanced Kidney Disease StudyNCT07812571 · 2026-11-01
NOT_YET_RECRUITINGPredicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel BiomarkersNCT06351813 · 2024-07-01
NOT_YET_RECRUITINGThe RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKDNCT05374291 · 2022-11-08
ENROLLING_BY_INVITATIONSGLT2 Inhibition in HemodialysisNCT05179668 · 2022-10-01
COMPLETEDDAPAgliflozin for Renal Protection in Heart Transplant RecipientsNCT05321706 · 2022-06-08
ACTIVE_NOT_RECRUITINGEffects of Different Forms of a Natural Heart Hormone on Blood Pressure and Fluid Balance in Healthy VolunteersNCT07606183 · 2022-05-01
COMPLETEDPilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on HemoDIALsisNCT04641650 · 2021-07-21
COMPLETEDPatient-Derived Stem Cell Therapy for Diabetic Kidney DiseaseNCT03840343 · 2019-10-23
TERMINATEDFREquent DIalysis & Markers of Cardiac Strain and Injury, Physical Fitness, Habitual Physical Activity & Quality of LifeNCT03925454 · 2019-03-19
COMPLETEDA Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney FunctionNCT03332186 · 2018-03-15
COMPLETEDVasQ External Support for Arteriovenous FistulaNCT03242343 · 2017-11-29
COMPLETEDNew Biomarkers in Heart- and Renal FailureNCT02830464 · 2016-08-01
COMPLETEDAcute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis PatientsNCT02753868 · 2016-02-01
COMPLETEDHealthy.io Method Comparison & User Performance StudyNCT02785445 · 2015-10-01
COMPLETEDProtocolized Diuretic Strategy in Cardiorenal FailureNCT01921829 · 2013-11-01
TERMINATEDErythropoietin (EPO) to Protect Renal Function After Cardiac SurgeryNCT01423955 · 2011-10-01
COMPLETEDDonor Simvastatin Treatment in Organ TransplantationNCT01160978 · 2010-06-01
COMPLETEDSafety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal ImpairmentNCT00881439 · 2009-04-01
TERMINATEDRenal Function in Adults With Congenital Heart Disease.NCT00807274 · 2008-09-01
WITHDRAWN1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal BiopsyNCT00748072 · 2008-08-01
COMPLETEDCardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney DonationNCT01564966 · 2008-04-01
COMPLETEDImpact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected PatientsNCT00551655 · 2007-05-01
COMPLETEDHemodilution and Outcome in Cardiac SurgeryNCT00364494 · 2006-11-01
TERMINATEDStudy Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant RecipientsNCT00369382 · 2006-09-01
COMPLETEDAngiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac CatheterizationNCT00317252 · 2006-07-01
COMPLETEDPROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Undergoing Coronary AngiographyNCT00259441 · 2005-02-01
COMPLETEDNASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary CatheterizationNCT00356954 · 2005-02-01
COMPLETEDRECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency Undergoing Coronary AngiographyNCT00247325 · 2004-01-01
COMPLETEDAKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG)NCT00780845 · 2003-01-01
COMPLETEDStenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery StenosisNCT00150943 · 2000-06-01
COMPLETEDScreening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell TransplantNCT00001859 · 1999-06-04
COMPLETEDA Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects.NCT00364260 · 1997-12-01
COMPLETEDEpidemiology of Complications After Solid Organ Transplantation - EpCOT StudyNCT02991105 · 1985-01-01
ACTIVE_NOT_RECRUITINGProspective Controlled Study of Posttransplant DiabetesNCT00006331
UNKNOWNCommon interventions
PlaceboDRUG5Dapagliflozin 10 MGDRUG2ACON U500 Mission® U500 Urine AnalyzerDEVICE1AliskirenDRUG1ascorbic acidDRUG1Aspirin tabletDRUG1Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher DoseBIOLOGICAL1Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower DoseBIOLOGICAL1BMS-986231DRUG1Control RxDRUG1cyclosporine or tacrolimusDRUG1Dapagliflozin 10 mg/day (oral)DRUG1DDAVPDRUG1DescovyDRUG1Different timing of red blood cells transfusion (substudy 1); Acute hemodilution versus no hemodilution (substudy 2)PROCEDURE1Dip.io Home Based Dipstick AnalyzerDEVICE1epoetin alfaDRUG1Erythropoietin zetaDRUG1exerciseBEHAVIORAL1FinerenoneDRUG1Hemodialysis treatmentPROCEDURE1Hold ACEI or ARBDRUG1Infusion of two different cardiac peptides plus vehicleOTHER1Iodixanol(Drug)DRUG1N-acetylcysteinDRUG1
Leading sponsors
Seoul National University Hospital
3
University Medical Center Groningen
2
AIDS Arms Inc.
1
Bristol-Myers Squibb
1
Centre Hospitalier Saint Joseph Saint Luc de Lyon
1
Hamilton Health Sciences Corporation
1
Healthy.io Ltd.
1
Helsinki University Central Hospital
1
Hospital de Base
1
Istanbul University
1
Janssen-Ortho Inc., Canada
1
Kelly V. Liang, MD
1
King's College Hospital NHS Trust
1
Laminate Medical Technologies
1
Mayo Clinic
1
Trial status mix
COMPLETED23
TERMINATED4
ACTIVE_NOT_RECRUITING2
NOT_YET_RECRUITING2
ENROLLING_BY_INVITATION1
RECRUITING1
UNKNOWN1
WITHDRAWN1
Phase mix
PHASE36
PHASE46
PHASE25
NA4
PHASE12
EARLY_PHASE11
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.